| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Regulatory Affairs | SVP, Regulatory Affairs & Qual
1 company
Shamim Ruff last filed a Form 4 in May 2018, as SVP, Chief Regulatory Affairs at SRPT. Shamim Ruff's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 31,936 shares of SRPT. The SRPT filings lean toward selling, a net 40,949 shares.
Shamim Ruff has 11 Form 4 filings on record from September 2016 to May 2018, all as SVP, Chief Regulatory Affairs at Sarepta Therapeutics (SRPT), 2016–2018.
The 25 reported transactions were 11 option exercises, 6 open-market sales, 5 tax withholdings and 3 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $2.1M.
The largest open-market sale was 11,500 shares of SRPT at an average $50.00 on October 3, 2017, about $575K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs & Qual | Sale+OE | 10,000 | $55.00 | $550,000.00 | -27.0% | |
| Oct 3, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs & Qual | Sale+OE | 11,500 | $50.00 | $575,000.00 | -29.8% | |
| Jul 21, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs & Qual | Sale+OE | 12,138 | $42.97 | $521,572.00 | -36.6% | |
| Sep 22, 2016 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs & Qual | Sale+OE | 7,311 | $60.00 | $438,660.00 | -26.5% |